SBWire

The global surgical drapes market exhibit the presence of several tier 1, tier 2, and tier 3 companies. This is indicative of a highly competitive vendor landscape. According to a new study by Transparency Market Research (TMR), some of the prominent companies operating in the global surgical drapes market have resorted to strategies such as product differentiation, aggressive pricing, and product upgrades to buoy competitive strength. Besides these, several companies are forging distribution partnerships aimed at reached wider audiences, thereby expanding their regional and global footprint.

The players in the worldwide laboratory centrifuge market are concentrating on item launch with a technological distinction. The focused scene is broadly divided because of solid emergence of a few players. Organizations are likewise foreseen that they would concentrate on clinical trials, joint ventures, research and development, mergers, and acquisitions to stay in ahead of the opposition. A portion of the main players in the worldwide laboratory centrifuge market are Thermo Fisher Scientific Inc., Andreas Hettich GmbH & Co.KG, Hitachi Koki Co., Ltd. (Subsidiary of Hitachi, Ltd.), Sigma Laborzentrifugen GmbH, Cole-Parmer Instrument Company, LLC.( Subsidiary of GTCR firm), Sartorius AG, Eppendorf Group, QIAGEN N.V., Beckman Coulter, Inc. (Subsidiary of Danaher Corporation), and KUBOTA Corporation.

The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing for business players. Several market players are already on the lookout for better business strategies to garner a global footprint.

Transparency Market Research identifies Merck & Co., Inc., Eli Lilly and Company, Novartis AG, Pfizer, Inc., Amgen Inc., Novo Nordisk A/S, Lupin Pharmaceuticals, Inc., and AstraZeneca as some of the leading players operating in the global women's health market. The market is highly fragmented due to a strong presence of several local vendors. Mergers and acquisitions, research and development, and product innovations are expected to be some of the key strategies of these companies in the forthcoming years. Beyond cancer, these companies are also expected to focus on osteoporosis and conditions such as endometriosis to tap into the market potential of both developing as well as developed countries.

Companies operating in the global hysteroscopes market are banking upon collaborations and co-development agreements to improve their positions. In response to the surging demand for minimally invasive techniques, they are coming up with HD optical lenses with increased resolution that are built from special sapphire glass for proper visualization. They are also seen launching hysteroscopes with semi-flexible shaft at lower cost to up sales.

The global bovine blood plasma market is currently gaining strong traction from the increasing demand for nutritious products in the food industry and strong investments on the research and development of new drugs. According to a recent business intelligence publication by Transparency Market Research (TMR), the global bovine blood plasma market is considerably fragmented in nature with only a few players holding a considerable chunk of shares as of 2016.

The vendor landscape of the global dental restorative market is highly dynamic and competitive as the large number of companies serving across various segments of the market are focused on the development of innovative and technologically advanced products. The market has thus witnessed a surge in the number and varieties of deliverables and a massive rise in the intensity of competition, observes Transparency Market Research in a recent report.

An investigation was announced over potential securities laws violations by U.S. Silica Holdings, Inc. (NYSE: SLCA and certain of its directors and officers.

An investigation was announced for investors in shares of LogMeIn, Inc. (NASDAQ: LOGM) concerning potential breaches of fiduciary duties by certain directors and officers of LogMeIn, Inc..

Venator Materials PLC is under investigation over potential securities laws violations in connection with certain financial statements.

An investigation was announced concerning the takeover of Rowan Companies plc. by Ensco plc is unfair to NYSE: RDC stockholders.

Global Anxiety Disorders and Depression Treatment Market: Snapshot

Global Meningococcal Vaccines Market: Snapshot

The soaring demand for antibiotics, on account of the alarming rise in the prevalence of various infections and food-borne diseases, has provided a significant thrust to microbiology culture practices across the world over the last few years. According to the Centers for Disease Control and Prevention (CDC), in the U.S. alone, a total of 23.6 million cases of infectious and parasitic diseases were reported in 2010. Since microbiology culture is an efficient diagnosis method to detect the cause of a number of infectious diseases, its application in the production of antibiotic drugs is witnessing a remarkable rise, worldwide.

The impending patent expiration has resulted in the sluggish growth rate of the adalimumab market in Latin America. The entry of biosimilars has further aggravated the market's concerns. Transparency Market Research (TMR) pegs the valuation of the Latin America adalimumab market at US$994.8 mn in 2014. Expanding at a weak CAGR of 0.4% from 2015 to 2023, the market is forecast to reach US$1,186.4 mn by the end of 2023.

The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market's opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as AzaSite, Zymaxid, Moxeza, and Vigamox, are set to lose their marketing exclusivity very soon.

Hospital Acquired Infection Treatment Market: Snapshot

Global Pharmaceutical Excipients Market, by Function Binder, Lubricant, Filler, Coating, by Application Oral, Parenteral, Topical, by Product Organic Chemicals, Inorganic Chemicals - Global Forecast 2027

Demand for continuous monitoring due to rise in network complexities and security concerns to drive network monitoring market to reach USD 2.93 billion by 2023.

The passenger systems segment of the airport information systems market is projected to grow at a higher CAGR than the non-passenger systems segment during the forecast period.

A closer look at the overall Wireless Presenter business scenario presented through self-explanatory charts, tables, and graphics images add greater value to the study

Located in the heart of Prince George, BC, Rapha Dental Centre is a mission dedicated to dental care. The dental practice is housed in a modern facility where a qualified team of dentists and endodontic experts are always on their toes to deliver exceptional service to each visitor. The team takes a holistic approach to dental and oral care, offering a full continuum of quality treatments to adults and minors in a soothing and enchanting ambience. The team does not discriminate, attending existing as well as new patients with the same intensity and keenness.

“Global Semiconductor Equipment Market” report has added by Orbis research and ready to deliver to its clients. This report provides a well-organized in depth analysis of Semiconductor Equipment industry with types, Technologies, Applications between forecast period 2018-2023.

“Global Gaming Chips Market” report has added by Orbis research and ready to deliver to its clients. This report provides a well-organized in depth analysis of Gaming Chips industry between forecast period 2018-2023.

An investor, who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC), filed a lawsuit in the U.S. District Court for the Middle District of Tennessee over alleged Securities Laws violations by Acadia Healthcare Company Inc.